SARS-CoV Peptide Antigen Neg control
SARS-CoV Peptide Antigen Neg control
This peptide corresponds to HBcAg-derived H-2b-restricted peptide, used as a negative control in HLA-A binding studies.
Online Inquiry
| CAT# | S29004 |
| Sequence | One Letter Code: AYRPPNAPIL
Three-Letter Code: H-Ala-Tyr-Arg-Pro-Pro-Asn-Ala-Pro-Ile-Leu-OH |
| Purity | % Peak Area by HPLC ≥ 95% |
| Size | 1 mg NET peptide |
Storage | -20°C |
References | 1. Lv Y, et al. Identification of a novel conserved HLA-A* 0201-restricted epitope from the spike protein of SARS-CoV. BMC immunology. 2009 Dec 1;10(1):61.2. Zhou M et al. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. The Journal of Immunology. 2006 Aug 15;177(4):2138-45. |
Write a review
Ask a question
My Review for SARS-CoV Peptide Antigen Neg control
Required fields are marked with *
×
Ask a Question for SARS-CoV Peptide Antigen Neg control
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
